Compare Tango Therapeutics Inc. (TNGX) vs Clear Secure Inc (YOU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Clear Secure Inc — how do they compare? Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B), while Clear Secure Inc trades at $44.26 (market cap $4.49B). The key difference: Clear Secure Inc is the larger of the two by market cap, and Clear Secure Inc pays a 1.32% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Clear Secure Inc for 20 Days on average.
| TNGX | YOU | |
|---|---|---|
Market Cap | $3.75B | $4.49B |
Volume | 9,619,106 | 1,674,277 |
Sector | Health | Technology |
52-Week High | $32.90 | $62.36 |
52-Week Low | $7.50 | $30.47 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $2.77B | $3.64B |
Dividend Yield | — | 1.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Clear Secure (YOU) trades at $43.52, up 2.5% over the past day, with a mixed technical picture showing bearish moving averages but neutral oscillators. Fundamentally, the company reported strong Q2 2026 results with EPS of $0.49 beating estimates, revenue growth of 27% year-over-year, and robust profitability metrics including a 66.66% gross margin. Recent developments include a strategic partnership with CrowdStrike and the launch of corporate memberships.
The outlook is positive given accelerating membership growth and expanding margins, though risks include competitive pressures and reliance on airport services. Analysts are generally bullish with a consensus price target of $61.40, representing significant upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Clear Secure Inc
Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →
